Agenus Stock Forum

$Agenus (AGEN.US)$
Agenus Publishes Seminal Study on Botensilimab’s Activity in Treatment-Resistant Cancers
Agenus Inc. (NASDAQ: AGEN) has published a groundbreaking study in Cancer Discovery on botensilimab, their novel Fc-enhanced anti-CTLA-4 antibody. The study highlights botensilimab's effectiveness against treatment-resistant cancers, including those unresponsive to conventional immunotherapy. Key findings include:
1. Demonstrated activity across multiple cancer types
2. Unique Fc-enhanc...

$Agenus (AGEN.US)$ why the calls are so cheap?

$Agenus (AGEN.US)$
BID AND ASK TO FAR MUST SELL ALL AND DELETE 👹🗡️🔥👺💣

$Agenus (AGEN.US)$ gap up next week from overselling

$Agenus (AGEN.US)$fail in delivery timely

$Agenus (AGEN.US)$ FDA never liked Garo. He go played again.

The market does not like biotech failure in primary endpoint.
$Agenus (AGEN.US)$

$Agenus (AGEN.US)$ ..why drop so dip??

So $Agenus (AGEN.US)$ owner bought shares at some low price at 0.6, then the price went down to 0.3 then reverse split.
Now the price is $15.00. Sometimes things get worse before it get better.
You could be a day trader and make your profit or cut losses or an investor and hold on.
I see some possibilities in this company and reverse split is to consolidate compliance. Now the ethics of the management or if they consider investor or shareholder investment is another d...

$Agenus (AGEN.US)$ Reuters· 5 mins ago
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/Bal Therapy for Relapsed or Refractory Metastatic Colorectal Cancer